Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
ABBV

AbbVie

$89.94

-2.27 (-2.46%)

, ALXN

Alexion

$126.59

-2.36 (-1.83%)

08:09
10/19/18
10/19
08:09
10/19/18
08:09
Conference/Events
The ACR and ARHP to hold annual meeting »

American College of…

ABBV

AbbVie

$89.94

-2.27 (-2.46%)

ALXN

Alexion

$126.59

-2.36 (-1.83%)

AMGN

Amgen

$202.78

(0.00%)

AUPH

Aurinia Pharmaceuticals

$5.69

-0.18 (-3.07%)

BMY

Bristol-Myers

$56.01

-2.9 (-4.92%)

CELG

Celgene

$82.94

-1.31 (-1.55%)

DGX

Quest Diagnostics

$102.37

0.02 (0.02%)

DNA

Bought by RHHBY

$0.00

(0.00%)

FLXN

Flexion

$18.63

0.03 (0.16%)

GILD

Gilead

$74.17

-1.45 (-1.92%)

GSK

GlaxoSmithKline

$39.62

-0.12 (-0.30%)

REGN

Regeneron

$395.39

-3.29 (-0.83%)

RARE

Ultragenyx

$64.10

-1.89 (-2.86%)

QDEL

Quidel

$67.53

-0.47 (-0.69%)

PFE

Pfizer

$44.02

-0.55 (-1.23%)

NVS

Novartis

$86.24

0.9 (1.05%)

MRK

Merck

$72.22

0.42 (0.58%)

MCK

McKesson

$132.70

-2.33 (-1.73%)

LLY

Eli Lilly

$113.31

-0.28 (-0.25%)

TMO

Thermo Fisher

$229.64

-5 (-2.13%)

TKPYY

Takeda Pharmaceutical

$0.00

(0.00%)

SELB

Selecta Biosciences

$15.14

-0.16 (-1.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 19

    Oct

  • 20

    Oct

  • 22

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 29

    Oct

  • 30

    Oct

  • 30

    Oct

  • 31

    Oct

  • 02

    Nov

  • 06

    Nov

  • 06

    Nov

  • 06

    Nov

  • 07

    Nov

  • 09

    Nov

  • 27

    Nov

  • 11

    Jan

  • 16

    Feb

  • 18

    Feb

  • 28

    Apr

  • 13

    May

Yesterday
OMED

OncoMed

$2.70

0.5 (22.73%)

, CELG

Celgene

$84.25

-0.025 (-0.03%)

07:24
10/18/18
10/18
07:24
10/18/18
07:24
Hot Stocks
Celgene ends agreement with OncoMed with respect to rosmantuzumab »

OncoMed Pharmaceuticals…

OMED

OncoMed

$2.70

0.5 (22.73%)

CELG

Celgene

$84.25

-0.025 (-0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 19

    Oct

  • 25

    Oct

  • 29

    Oct

Over a week ago
CELG

Celgene

$84.22

-2.56 (-2.95%)

07:35
10/11/18
10/11
07:35
10/11/18
07:35
Hot Stocks
Celgene says survey shows people with MS want more information on brain atrophy »

A new survey examines the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 19

    Oct

  • 25

    Oct

  • 29

    Oct

CELG

Celgene

$86.78

-0.7 (-0.80%)

07:35
10/10/18
10/10
07:35
10/10/18
07:35
Hot Stocks
Celgene to present new analyses from Phase 3 trials of ozanimod »

Celgene Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 19

    Oct

  • 25

    Oct

  • 29

    Oct

BGNE

BeiGene

$142.42

-4.19 (-2.86%)

, CELG

Celgene

$86.78

-0.7 (-0.80%)

06:05
10/10/18
10/10
06:05
10/10/18
06:05
Hot Stocks
BeiGene: China's SMIA includes VIDAZA on national reimbursement drug list »

BeiGene (BGNE) announced…

BGNE

BeiGene

$142.42

-4.19 (-2.86%)

CELG

Celgene

$86.78

-0.7 (-0.80%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 19

    Oct

  • 25

    Oct

  • 29

    Oct

  • 27

    Nov

FTSV

Forty Seven

$12.55

-1.19 (-8.66%)

, CELG

Celgene

$87.25

-0.23 (-0.26%)

14:43
10/09/18
10/09
14:43
10/09/18
14:43
Recommendations
Forty Seven, Celgene analyst commentary at Credit Suisse »

Forty Seven selloff on…

FTSV

Forty Seven

$12.55

-1.19 (-8.66%)

CELG

Celgene

$87.25

-0.23 (-0.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 19

    Oct

  • 25

    Oct

  • 29

    Oct

CELG

Celgene

$87.17

-0.31 (-0.35%)

14:38
10/09/18
10/09
14:38
10/09/18
14:38
Hot Stocks
Celgene terminates study of CC-90002 in Acute Myeloid Leukemia »

A ClinicalTrials.gov post…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 19

    Oct

  • 25

    Oct

  • 29

    Oct

CELG

Celgene

$87.48

0.21 (0.24%)

16:40
10/08/18
10/08
16:40
10/08/18
16:40
Hot Stocks
Celgene says Phase 3 Otezla study meets primary, secondary endpoints »

Celgene Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 19

    Oct

  • 25

    Oct

  • 29

    Oct

VCEL

Vericel

$14.37

-0.54 (-3.62%)

, FLXN

Flexion

$18.24

-0.56 (-2.98%)

04:55
10/05/18
10/05
04:55
10/05/18
04:55
Conference/Events
Alliance for Regenerative Medicine (ARM) to hold a conference »

Cell & Gene Meeting…

VCEL

Vericel

$14.37

-0.54 (-3.62%)

FLXN

Flexion

$18.24

-0.56 (-2.98%)

MDXG

MiMedx

$6.46

0.12 (1.89%)

ADAP

Adaptimmune

$14.18

0.07 (0.50%)

ABEO

Abeona Therapeutics

$11.43

-0.47 (-3.95%)

BCLI

BrainStorm

$3.75

-0.14 (-3.60%)

TIG

TiGenix

$0.00

(0.00%)

AVRO

Avrobio

$23.35

-0.1 (-0.43%)

JUNO

Acquired by CELG

$0.00

(0.00%)

BTX

BioTime

$2.22

-0.04 (-1.77%)

NITE

Nightstar Therapeutics

$17.99

-0.65 (-3.49%)

BLUE

Bluebird Bio

$140.70

-3.36 (-2.33%)

AST

Asterias

$1.15

-0.15 (-11.54%)

GSK

GlaxoSmithKline

$40.16

-0.345 (-0.85%)

WXXWY

Wuxi Biologics

$0.00

(0.00%)

CLBS

Caladrius

$5.51

0.01 (0.18%)

SGMO

Sangamo

$14.82

-0.51 (-3.33%)

BOLD

Audentes Therapeutics

$34.22

-0.76 (-2.17%)

ONVO

Organovo

$1.14

-0.02 (-1.72%)

SNY

Sanofi

$44.10

-0.51 (-1.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Oct

  • 09

    Oct

  • 19

    Oct

  • 20

    Oct

  • 28

    Oct

  • 29

    Oct

  • 01

    Dec

  • 28

    Jan

  • 22

    Mar

  • 28

    Apr

ALNY

Alnylam

$88.16

0.97 (1.11%)

, AMGN

Amgen

$206.87

-0.77 (-0.37%)

09:02
10/04/18
10/04
09:02
10/04/18
09:02
Conference/Events
Cantor Fitzgerald biotech analysts to hold an analyst/industry conference call »

Biotech Analysts Young…

ALNY

Alnylam

$88.16

0.97 (1.11%)

AMGN

Amgen

$206.87

-0.77 (-0.37%)

BMRN

BioMarin

$99.73

0.71 (0.72%)

CELG

Celgene

$91.85

0.01 (0.01%)

GILD

Gilead

$79.01

0.33 (0.42%)

INCY

Incyte

$69.94

0.1 (0.14%)

MYOK

MyoKardia

$60.32

0.11 (0.18%)

PBYI

Puma Biotechnology

$46.40

-0.28 (-0.60%)

PTCT

PTC Therapeutics

$45.27

-0.01 (-0.02%)

REGN

Regeneron

$403.15

2.67 (0.67%)

SRPT

Sarepta

$146.98

4.17 (2.92%)

TSRO

Tesaro

$41.81

1.89 (4.73%)

VRTX

Vertex

$192.24

0.28 (0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Oct

  • 16

    Oct

  • 17

    Oct

  • 19

    Oct

  • 20

    Oct

  • 22

    Oct

  • 25

    Oct

  • 28

    Oct

  • 29

    Oct

  • 09

    Nov

  • 27

    Nov

  • 28

    Apr

  • 13

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.